1.
Clinical and Experimental Rheumatology
; 38(6):1215-1222, 2020.
Article
in English
| GIM | ID: covidwho-1013702
ABSTRACT
Objectives: To identify predictors of clinical improvement and intubation/death in tocilizumab-treated severe COVID19, focusing on IL6 and CRP longitudinal monitoring.